The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity
- PMID: 11509586
- DOI: 10.4049/jimmunol.167.5.2479
The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity
Abstract
LIGHT is a recently identified member of the TNF superfamily that is up-regulated upon activation of T cells. Herpesvirus entry mediator, one of its receptors, is constitutively expressed on immature dendritic cells (DCs). In this report, we demonstrate that LIGHT induces partial DC maturation as demonstrated by Ag presentation and up-regulation of adhesion and costimulatory molecules. LIGHT-stimulated DCs show reduced macropinocytosis and enhanced allogeneic stimulatory capacity but fail to produce significant amounts of IL-12, IL-6, IL-1beta, or TNF-alpha compared with unstimulated DCs. However, LIGHT cooperates with CD154 (CD40 ligand) in DC maturation, with particular potentiation of allogeneic T cell proliferation and cytokine secretion of IL-12, IL-6, and TNF-alpha. Moreover, LIGHT costimulation allows DCs to prime in vitro-enhanced specific CTL responses. Our results suggest that LIGHT plays an important role in DC-mediated immune responses by regulating CD154 signals and represents a potential tool for DC-based cancer immunotherapy.
Similar articles
-
LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response.J Immunol. 2000 Apr 15;164(8):4105-10. doi: 10.4049/jimmunol.164.8.4105. J Immunol. 2000. PMID: 10754304
-
Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals.J Immunol. 2003 Feb 15;170(4):1797-805. doi: 10.4049/jimmunol.170.4.1797. J Immunol. 2003. PMID: 12574344
-
Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.Cancer Res. 2000 Aug 15;60(16):4485-92. Cancer Res. 2000. PMID: 10969796
-
LIGHT-HVEM signaling and the regulation of T cell-mediated immunity.Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):289-96. doi: 10.1016/s1359-6101(03)00031-5. Cytokine Growth Factor Rev. 2003. PMID: 12787566 Review.
-
Prospects for CD40-directed experimental therapy of human cancer.Cancer Gene Ther. 2003 Jan;10(1):1-13. doi: 10.1038/sj.cgt.7700527. Cancer Gene Ther. 2003. PMID: 12489023 Review.
Cited by
-
The nature of activatory and tolerogenic dendritic cell-derived signal II.Front Immunol. 2013 Feb 28;4:53. doi: 10.3389/fimmu.2013.00053. eCollection 2013. Front Immunol. 2013. PMID: 23450201 Free PMC article.
-
Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis.J Exp Med. 2002 Jun 17;195(12):1613-24. doi: 10.1084/jem.20020215. J Exp Med. 2002. PMID: 12070288 Free PMC article.
-
HVEM signalling promotes colitis.PLoS One. 2011 Apr 18;6(4):e18495. doi: 10.1371/journal.pone.0018495. PLoS One. 2011. PMID: 21533159 Free PMC article.
-
HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell function.Cell Oncol (Dordr). 2024 Oct;47(5):1779-1796. doi: 10.1007/s13402-024-00959-1. Epub 2024 May 29. Cell Oncol (Dordr). 2024. PMID: 38809326
-
Axl acts as a tumor suppressor by regulating LIGHT expression in T lymphoma.Oncotarget. 2017 Mar 28;8(13):20645-20655. doi: 10.18632/oncotarget.15830. Oncotarget. 2017. PMID: 28423548 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials